Abstract:An inevitable consequence of humans living in the Aluminium Age is the presence of aluminium in the brain. This non-essential, neurotoxic metal gains entry to the brain throughout all stages of human development, from the foetus through to old age. Human exposure to myriad forms of this ubiquitous and omnipresent metal makes its presence in the brain inevitable, while the structure and physiology of the brain makes it particularly susceptible to the accumulation of aluminium with age. In spite of aluminium's c… Show more
“…The addition of aluminium appears to impact the reductive capacity of Aβ by increasing its ability to reduce iron(III) in suspension. Aluminium is also not naturally found within human tissues [51], and therefore its removal from brain tissue may act to reduce Aβ neurotoxicity, while not impacting healthy brain functions. In summary, key insights into the relationship between Aβ and iron have been made that provide valuable insights into the role played by iron in AD pathology.…”
For decades, a link between increased levels of iron and areas of Alzheimer's disease (AD) pathology has been recognized, including AD lesions comprised of the peptide β-amyloid (Aβ). Despite many observations of this association, the relationship between Aβ and iron is poorly understood. Using X-ray microspectroscopy, X-ray absorption spectroscopy, electron microscopy and spectrophotometric iron(II) quantification techniques, we examine the interaction between Aβ(1–42) and synthetic iron(III), reminiscent of ferric iron stores in the brain. We report Aβ to be capable of accumulating iron(III) within amyloid aggregates, with this process resulting in Aβ-mediated reduction of iron(III) to a redox-active iron(II) phase. Additionally, we show that the presence of aluminium increases the reductive capacity of Aβ, enabling the redox cycling of the iron. These results demonstrate the ability of Aβ to accumulate iron, offering an explanation for previously observed local increases in iron concentration associated with AD lesions. Furthermore, the ability of iron to form redox-active iron phases from ferric precursors provides an origin both for the redox-active iron previously witnessed in AD tissue, and the increased levels of oxidative stress characteristic of AD. These interactions between Aβ and iron deliver valuable insights into the process of AD progression, which may ultimately provide targets for disease therapies.
“…The addition of aluminium appears to impact the reductive capacity of Aβ by increasing its ability to reduce iron(III) in suspension. Aluminium is also not naturally found within human tissues [51], and therefore its removal from brain tissue may act to reduce Aβ neurotoxicity, while not impacting healthy brain functions. In summary, key insights into the relationship between Aβ and iron have been made that provide valuable insights into the role played by iron in AD pathology.…”
For decades, a link between increased levels of iron and areas of Alzheimer's disease (AD) pathology has been recognized, including AD lesions comprised of the peptide β-amyloid (Aβ). Despite many observations of this association, the relationship between Aβ and iron is poorly understood. Using X-ray microspectroscopy, X-ray absorption spectroscopy, electron microscopy and spectrophotometric iron(II) quantification techniques, we examine the interaction between Aβ(1–42) and synthetic iron(III), reminiscent of ferric iron stores in the brain. We report Aβ to be capable of accumulating iron(III) within amyloid aggregates, with this process resulting in Aβ-mediated reduction of iron(III) to a redox-active iron(II) phase. Additionally, we show that the presence of aluminium increases the reductive capacity of Aβ, enabling the redox cycling of the iron. These results demonstrate the ability of Aβ to accumulate iron, offering an explanation for previously observed local increases in iron concentration associated with AD lesions. Furthermore, the ability of iron to form redox-active iron phases from ferric precursors provides an origin both for the redox-active iron previously witnessed in AD tissue, and the increased levels of oxidative stress characteristic of AD. These interactions between Aβ and iron deliver valuable insights into the process of AD progression, which may ultimately provide targets for disease therapies.
“…Living in the 'aluminium age' ensures that the myriad ways in which we are exposed to aluminium today will be even more numerous tomorrow. Aluminium in human brain tissue is the inevitable consequence of this burgeoning exposure [2]. However, what are the consequences of aluminium in human brain tissue?…”
“…While aluminium's neurotoxicity is incontrovertible, it is much more difficult to understand the risk that this neurotoxin poses to human health. Aluminium is neurotoxic because it possesses an extensive biochemical toolkit and because neurons are predisposed by their longevity toward its intracellular accumulation up to and beyond toxic thresholds [2]. Aluminium is neurotoxic as the establishment of toxicity thresholds can result in neuronal dysfunction, neurodegeneration and ultimately neuronal cell death through a continuum of disruptive events from classical apoptosis through to sudden and violent necrosis [3].…”
Section: Aluminium the Neurotoxinmentioning
confidence: 99%
“…What is currently unknown is how our burgeoning exposure to aluminium in everyday life is contributing toward toxic thresholds in individuals and in populations. Aging is a major risk factor for neurodegenerative diseases and it is also a significant risk factor for establishing brain burdens of aluminium [2]. The latter are not expected to achieve levels responsible for overt toxicity, such as were found for dialysis encephalopathy [11], but do they approach or exceed those required for covert toxicity, including exacerbation of an ongoing disease state?…”
Section: Aluminium An Everyday Neurotoxinmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.